PRMT5-mediated metabolic reprogramming drives lactate-dependent PD-L1 activation and immune evasion in colorectal cancer
Year: 2026
Type: article
Abstract: Patients with PRMT5-high colorectal cancer (PRMT5 hi CRC) exhibit poor prognosis, yet how PRMT5 coordinates metabolism and immune evasion remains unclear. Here, we demonstrate that elevated PRMT5 catalyzes symmetric dimethylation of pyruvate kinase M2 (PKM2), enhancing its active tetramer formation and glycolytic flux, leading to lactate accumulation. This lactate serves as a substrate for AARS2-mediated lactylation of centromere protein A (CENPA) at lysine 124. Lactylated CENPA shows enhanced affinity for KPNA2 facilitating its nuclear translocation where it acts as a transcriptional co-activator that interacts with the transcription factor YY1 to cooperatively upregulate programmed death-ligand 1 (PD-L1) expression. Consequently, elevated PD-L1 suppresses cytotoxic T-cell activity, promoting tumor immune evasion and accelerating CRC progression. Clinically, PRMT5 levels positively correlate with PD-L1 expression and predict unfavorable outcomes. Through high-throughput screening, we identify a potent compound that disrupts the PRMT5-PKM2 interaction. In vitro , this disruption synergizes with anti-PD-1 treatment to enhance immune-mediated tumor cell killing. Our findings reveal a novel PRMT5-PKM2-lactate-CENPA/YY1-PD-L1 axis linking metabolism to immune suppression, and nominate PRMT5-PKM2 interface as a potential therapeutic target to improve outcomes in PRMT5 hi CRC.
Source: Frontiers in Pharmacology
Authors: Li Li(Investigation, Methodology, Writing – original draft), Rongjun Xie(Investigation, Methodology, Writing – original draft, Writing – review & editing), Zhe Yang(Investigation, Methodology, Writing – original draft), Li Zhao(Investigation, Methodology, Writing – original draft), Xianzhou Lu(Data curation, Formal analysis, Writing – review & editing), Longfei Liu(Methodology, Project administration, Supervision, Writing – review & editing)
Institution: University of South China
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7237207003
